EMEA-000332-PIP01-08-M13

Key facts

Invented name
  • Briviact (in Italy: Nubriveo)
  • Briviact
Active substance
Brivaracetam
Therapeutic area
Neurology
Decision number
P/0051/2018
PIP number
EMEA-000332-PIP01-08-M13
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral solution
  • Solution for injection
Condition(s) / indication(s)
  • Treatment of epilepsy with partial-onset seizures
  • Treatment of neonatal seizures
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
UCB Pharma S.A.
Tel. +32 (0)25599314
E-mail: peter.dedeken@ucb.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating